Skip to main content

Advertisement

Table 6 Adjusted odds ratios and 95% confidence interval for allergic outcomes

From: Maternal phthalate exposure and asthma, rhinitis and eczema in 552 children aged 5 years; a prospective cohort study

OutcomeMEP OR and 95% CIΣMBP
OR and 95% CI
ΣDEHPm
OR and 95% CI
ΣDiNPm
OR and 95% CI
Wheeze within the last 2 years1.00 (0.90,1.11)0.86 (0.72,1.04)0.91 (0.78,1.07)0.89 (0.78,1.02)
Self-reported asthma1.02 (0.82,1.27)0.95 (0.67,1.36)0.98 (0.72,1.33)0.99 (0.77,1.28)
Doctor-diagnosed asthma0.91 (0.73,1.12)0.80 (0.57,1.13)0.91 (0.68,1.21)0.94 (0.73,1.21)
Use of medicine against asthma/cold0.99 (0.88,1.13)0.86 (0.70,1.08)0.87 (0.72,1.04)0.85 (0.72,1.00)
Self-reported eczema0.81*(0.68,0.96)0.90 (0.70,1.15)1.00 (0.80,1.26)1.03 (0.87,1.22)
Doctor-diagnosed eczema0.82 (0.66,1.01)0.79 (0.55,1.10)0.94 (0.71,1.25)1.10 (0.90,1.36)
Medicine against eczema0.88 (0.70,1.10)0.84 (0.58,1.23)1.02 (0.72,1.43)1.24 (1.00,1.55)
Self-reported rhinitis0.91 (0.75,1.04)1.11 (0.84,1.46)1.21 (0.93,1.58)1.15 (0.97,1.36)
  1. Abbreviations: OR odds ratio; 95% CI 95% confidence interval; MEP monoethyl phthalate; ΣMBP Monobutyl phthalate (i + n), ΣDiNPm sum of Di-isonyl phthalate metabolites; ΣDEHPm sum of Di-2-ethylhexyl phthalate metabolites
  2. Note: ORs were adjusted for maternal age, maternal education, parity and family history of asthma/allergy. * = p < 0.05